{"id":"https://openalex.org/W2096083860","doi":"https://doi.org/10.2337/dc11-0324","title":"Initial Angiotensin Receptor Blockade\u2013Induced Decrease in Albuminuria Is Associated With Long-Term Renal Outcome in Type 2 Diabetic Patients With Microalbuminuria","display_name":"Initial Angiotensin Receptor Blockade\u2013Induced Decrease in Albuminuria Is Associated With Long-Term Renal Outcome in Type 2 Diabetic Patients With Microalbuminuria","alternate_titles":[],"publication_year":2011,"publication_date":"2011-08-19","ids":{"openalex":"https://openalex.org/W2096083860","doi":"https://doi.org/10.2337/dc11-0324","mag":"2096083860","pmid":"https://pubmed.ncbi.nlm.nih.gov/21788629","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3161288"},"language":"en","primary_location":{"id":"doi:10.2337/dc11-0324","doi":"https://doi.org/10.2337/dc11-0324","is_oa":true,"landing_page_url":"https://doi.org/10.2337/dc11-0324","pdf_url":"https://diabetesjournals.org/care/article-pdf/34/9/2078/609567/2078.pdf","source":{"id":"https://openalex.org/S49878492","display_name":"Diabetes Care","issn_l":"0149-5992","issn":["0149-5992","1935-5548"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2096083860"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://diabetesjournals.org/care/article-pdf/34/9/2078/609567/2078.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5050197978","display_name":"Merel E. Hellemons","orcid":"https://orcid.org/0000-0002-6666-5027","observed_orcids":["https://orcid.org/0000-0002-6666-5027"]},"institutions":[{"id":"https://openalex.org/I1334415907","display_name":"University Medical Center Groningen","ror":"https://ror.org/03cv38k47","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I1334415907"]},{"id":"https://openalex.org/I169381384","display_name":"University of Groningen","ror":"https://ror.org/012p63287","country_code":"NL","type":"education","lineage":["https://openalex.org/I169381384"]}],"countries":["NL"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Merel E. Hellemons","raw_affiliation_strings":["Department of Clinical Pharmacology, University Medical Center of Groningen, University of Groningen, Groningen, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, University Medical Center of Groningen, University of Groningen, Groningen, the Netherlands","institution_ids":["https://openalex.org/I1334415907","https://openalex.org/I169381384"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012676820","display_name":"Frederik Persson","orcid":"https://orcid.org/0000-0001-6242-6638","observed_orcids":["https://orcid.org/0000-0001-6242-6638"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Frederik Persson","raw_affiliation_strings":["Steno Diabetes Center, Gentofte, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Steno Diabetes Center, Gentofte, Denmark","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038949732","display_name":"Stephan J. L. Bakker","orcid":"https://orcid.org/0000-0003-3356-6791","observed_orcids":["https://orcid.org/0000-0003-3356-6791"]},"institutions":[{"id":"https://openalex.org/I1334415907","display_name":"University Medical Center Groningen","ror":"https://ror.org/03cv38k47","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I1334415907"]},{"id":"https://openalex.org/I169381384","display_name":"University of Groningen","ror":"https://ror.org/012p63287","country_code":"NL","type":"education","lineage":["https://openalex.org/I169381384"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Stephan J.L. Bakker","raw_affiliation_strings":["Department of Clinical Pharmacology, University Medical Center of Groningen, University of Groningen, Groningen, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, University Medical Center of Groningen, University of Groningen, Groningen, the Netherlands","institution_ids":["https://openalex.org/I1334415907","https://openalex.org/I169381384"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085592050","display_name":"Peter R Rossing","orcid":"https://orcid.org/0000-0002-1531-4294","observed_orcids":["https://orcid.org/0000-0002-1531-4294","https://orcid.org/0009-0004-5073-0009"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Peter Rossing","raw_affiliation_strings":["Steno Diabetes Center, Gentofte, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Steno Diabetes Center, Gentofte, Denmark","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111749912","display_name":"Hans\u2010Henrik Parving","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I204337017","display_name":"Aarhus University","ror":"https://ror.org/01aj84f44","country_code":"DK","type":"education","lineage":["https://openalex.org/I204337017"]},{"id":"https://openalex.org/I2802567020","display_name":"Copenhagen University Hospital","ror":"https://ror.org/05bpbnx46","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2802567020"]}],"countries":["DK"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hans-Henrik Parving","raw_affiliation_strings":["Department of Medical Endocrinology, University Hospital of Copenhagen, Copenhagen, Denmark","Faculty of Health Sciences, Aarhus University, Aarhus, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Endocrinology, University Hospital of Copenhagen, Copenhagen, Denmark","institution_ids":["https://openalex.org/I2802567020"]},{"raw_affiliation_string":"Faculty of Health Sciences, Aarhus University, Aarhus, Denmark","institution_ids":["https://openalex.org/I204337017"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045497276","display_name":"Dick de Zeeuw","orcid":"https://orcid.org/0000-0003-3434-7777","observed_orcids":["https://orcid.org/0000-0003-3434-7777"]},"institutions":[{"id":"https://openalex.org/I1334415907","display_name":"University Medical Center Groningen","ror":"https://ror.org/03cv38k47","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I1334415907"]},{"id":"https://openalex.org/I169381384","display_name":"University of Groningen","ror":"https://ror.org/012p63287","country_code":"NL","type":"education","lineage":["https://openalex.org/I169381384"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Dick De Zeeuw","raw_affiliation_strings":["Department of Clinical Pharmacology, University Medical Center of Groningen, University of Groningen, Groningen, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, University Medical Center of Groningen, University of Groningen, Groningen, the Netherlands","institution_ids":["https://openalex.org/I1334415907","https://openalex.org/I169381384"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5031624913","display_name":"Hiddo J.L. Heerspink","orcid":"https://orcid.org/0000-0002-3126-3730","observed_orcids":["https://orcid.org/0000-0002-3126-3730"]},"institutions":[{"id":"https://openalex.org/I1334415907","display_name":"University Medical Center Groningen","ror":"https://ror.org/03cv38k47","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I1334415907"]},{"id":"https://openalex.org/I169381384","display_name":"University of Groningen","ror":"https://ror.org/012p63287","country_code":"NL","type":"education","lineage":["https://openalex.org/I169381384"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hiddo J. Lambers Heerspink","raw_affiliation_strings":["Department of Clinical Pharmacology, University Medical Center of Groningen, University of Groningen, Groningen, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, University Medical Center of Groningen, University of Groningen, Groningen, the Netherlands","institution_ids":["https://openalex.org/I1334415907","https://openalex.org/I169381384"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5050197978"],"corresponding_institution_ids":["https://openalex.org/I1334415907","https://openalex.org/I169381384"],"apc_list":null,"apc_paid":null,"fwci":6.1152,"has_fulltext":true,"cited_by_count":69,"citation_normalized_percentile":{"value":0.96527056,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"34","issue":"9","first_page":"2078","last_page":"2083"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/angiotensin-receptor-blockers","display_name":"angiotensin receptor blockers","score":0.9760000109672546},{"id":"https://openalex.org/keywords/irbesartan","display_name":"irbesartan","score":0.9900000095367432},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9139999747276306},{"id":"https://openalex.org/keywords/microalbuminuria","display_name":"microalbuminuria","score":0.9879999756813049},{"id":"https://openalex.org/keywords/albuminuria","display_name":"albuminuria","score":0.8550000190734863},{"id":"https://openalex.org/keywords/urinary-albumin-excretion","display_name":"urinary albumin excretion","score":0.8600000143051147},{"id":"https://openalex.org/keywords/systolic-blood-pressure-response","display_name":"systolic blood pressure response","score":0.8849999904632568},{"id":"https://openalex.org/keywords/estimated-glomerular-filtration-rate-decline","display_name":"estimated glomerular filtration rate decline","score":0.9549999833106995},{"id":"https://openalex.org/keywords/renal-outcomes","display_name":"renal outcomes","score":0.7289999723434448},{"id":"https://openalex.org/keywords/renal-protection","display_name":"renal protection","score":0.9240000247955322}],"concepts":[{"id":"https://openalex.org/C2781203188","wikidata":"https://www.wikidata.org/wiki/Q1676817","display_name":"Microalbuminuria","level":3,"score":0.930120587348938},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9249356985092163},{"id":"https://openalex.org/C2780259554","wikidata":"https://www.wikidata.org/wiki/Q947266","display_name":"Irbesartan","level":3,"score":0.8394914865493774},{"id":"https://openalex.org/C2776174234","wikidata":"https://www.wikidata.org/wiki/Q974792","display_name":"Albuminuria","level":3,"score":0.8331382870674133},{"id":"https://openalex.org/C159641895","wikidata":"https://www.wikidata.org/wiki/Q108377937","display_name":"Renal function","level":2,"score":0.7349680662155151},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6496901512145996},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.5400323271751404},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.4987654685974121},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4960702359676361},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4764595031738281},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.47547999024391174},{"id":"https://openalex.org/C2908929049","wikidata":"https://www.wikidata.org/wiki/Q65963433","display_name":"Angiotensin II","level":3,"score":0.44511377811431885},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.42768824100494385},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077405","descriptor_name":"Irbesartan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000419","descriptor_name":"Albuminuria","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000419","descriptor_name":"Albuminuria","qualifier_ui":"Q000652","qualifier_name":"urine","is_major_topic":false},{"descriptor_ui":"D001713","descriptor_name":"Biphenyl Compounds","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001794","descriptor_name":"Blood Pressure","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000652","qualifier_name":"urine","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005919","descriptor_name":"Glomerular Filtration Rate","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013777","descriptor_name":"Tetrazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D057911","descriptor_name":"Angiotensin Receptor Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":7,"locations":[{"id":"doi:10.2337/dc11-0324","doi":"https://doi.org/10.2337/dc11-0324","is_oa":true,"landing_page_url":"https://doi.org/10.2337/dc11-0324","pdf_url":"https://diabetesjournals.org/care/article-pdf/34/9/2078/609567/2078.pdf","source":{"id":"https://openalex.org/S49878492","display_name":"Diabetes Care","issn_l":"0149-5992","issn":["0149-5992","1935-5548"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2431320","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3161288","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3161288","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3161288/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"Text"},{"id":"pmid:21788629","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21788629","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes care","raw_type":"Journal Article"},{"id":"pmh:oai:pure.rug.nl:openaire_cris_publications/2c1eac54-167e-45c5-b892-72f366293f1d","doi":null,"is_oa":false,"landing_page_url":"https://hdl.handle.net/11370/2c1eac54-167e-45c5-b892-72f366293f1d","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hellemons, M E, Persson, F, Bakker, S J L, Rossing, P, Parving, H-H, De Zeeuw, D & Lambers Heerspink, H J 2011, 'initial angiotensin receptor blockade-induced decrease in albuminuria is associated with long-term renal outcome in type 2 diabetic patients with microalbuminuria : a post hoc analysis of the IRMA-2 trial', Diabetes Care, vol. 34, no. 9, pp. 2078-2083. https://doi.org/10.2337/dc11-0324","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:rug:oai:pure.rug.nl:publications/2c1eac54-167e-45c5-b892-72f366293f1d","doi":null,"is_oa":false,"landing_page_url":"https://research.rug.nl/en/publications/2c1eac54-167e-45c5-b892-72f366293f1d","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Diabetes Care, 34(9), 2078 - 2083. AMER DIABETES ASSOC","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.777.2234","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.777.2234","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ftp://ftp.ncbi.nlm.nih.gov/pub/pmc/90/28/2078.PMC3161288.pdf","raw_type":"text"}],"best_oa_location":{"id":"doi:10.2337/dc11-0324","doi":"https://doi.org/10.2337/dc11-0324","is_oa":true,"landing_page_url":"https://doi.org/10.2337/dc11-0324","pdf_url":"https://diabetesjournals.org/care/article-pdf/34/9/2078/609567/2078.pdf","source":{"id":"https://openalex.org/S49878492","display_name":"Diabetes Care","issn_l":"0149-5992","issn":["0149-5992","1935-5548"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2934826979","display_name":null,"funder_award_id":"T6-202","funder_id":"https://openalex.org/F4320322706","funder_display_name":"Top Institute Pharma"},{"id":"https://openalex.org/G7616450975","display_name":"Systems biology towards novel chronic kidney disease diagnosis and treatment","funder_award_id":"241544","funder_id":"https://openalex.org/F4320320300","funder_display_name":"European Commission"}],"funders":[{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"},{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320320300","display_name":"European Commission","ror":"https://ror.org/00k4n6c32"},{"id":"https://openalex.org/F4320322436","display_name":"Novo Nordisk","ror":"https://ror.org/0435rc536"},{"id":"https://openalex.org/F4320322706","display_name":"Top Institute Pharma","ror":"https://ror.org/01qmxzb47"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2096083860.pdf","grobid_xml":"https://content.openalex.org/works/W2096083860.grobid-xml"},"referenced_works_count":25,"referenced_works":["https://openalex.org/W1968443062","https://openalex.org/W1983539151","https://openalex.org/W1986924251","https://openalex.org/W1992719998","https://openalex.org/W2003670762","https://openalex.org/W2017268330","https://openalex.org/W2049490211","https://openalex.org/W2050071967","https://openalex.org/W2055864845","https://openalex.org/W2056976690","https://openalex.org/W2074349895","https://openalex.org/W2075429282","https://openalex.org/W2082767657","https://openalex.org/W2086350248","https://openalex.org/W2108595845","https://openalex.org/W2138670606","https://openalex.org/W2140776838","https://openalex.org/W2145555664","https://openalex.org/W2150392479","https://openalex.org/W2150964163","https://openalex.org/W2157109450","https://openalex.org/W2324062964","https://openalex.org/W2568019769","https://openalex.org/W2596624061","https://openalex.org/W3021250193"],"related_works":["https://openalex.org/W2071381646","https://openalex.org/W2331245168","https://openalex.org/W2991322050","https://openalex.org/W2118286022","https://openalex.org/W2128978422","https://openalex.org/W2052653818","https://openalex.org/W2114034422","https://openalex.org/W2137577644"],"abstract_inverted_index":{"OBJECTIVE:":[0],"We":[1],"aimed":[2],"to":[3,21,219],"investigate":[4],"the":[5,50,65,81,114,168,211,239,243,249],"individual":[6,66,82],"impact":[7],"of":[8,49,84,103,160,170,195,248,269],"initial":[9,229],"responses":[10],"in":[11,32,52,68,75,94,109,113,132,136,149,153,162,201,231,256],"urinary":[12],"albumin":[13],"excretion":[14],"(UAE)":[15],"and":[16,38,58,70,111,118,141,191,209,271],"systolic":[17],"blood":[18],"pressure":[19],"(SBP)":[20],"angiotensin":[22],"II":[23],"receptor":[24],"blocker":[25],"(ARB)":[26],"treatment":[27],"on":[28,88],"long-term":[29],"renal":[30,89,196],"outcome":[31,90],"patients":[33,258],"with":[34,54,167,204,236,259],"type":[35,260],"2":[36,56,101,261],"diabetes":[37],"microalbuminuria.":[39],"RESEARCH":[40],"DESIGN":[41],"AND":[42],"METHODS:":[43],"In":[44,122],"a":[45,128,145,178,187,192,205,272],"post":[46],"hoc":[47],"analysis":[48],"Irbesartan":[51],"Patients":[53],"Type":[55],"Diabetes":[57],"Microalbuminuria":[59],"(IRMA)-2":[60],"trial":[61],"we":[62,79],"first":[63],"assessed":[64],"variability":[67],"UAE":[69,110,133,154,156,163,189,217,232,241,263],"SBP":[71,112,137,139,150,176,206,226,250],"response":[72,86,218],"(0-6":[73],"months)":[74],"531":[76],"subjects.":[77],"Subsequently,":[78],"analyzed":[80],"effect":[83],"both":[85,202],"parameters":[87],"defined":[91],"as":[92],"change":[93,207,230],"estimated":[95],"glomerular":[96],"filtration":[97],"rate":[98,169,194],"(eGFR)":[99],"during":[100],"years":[102],"follow-up.":[104],"RESULTS:":[105],"The":[106,158,184,228],"median":[107],"reductions":[108],"population":[115],"were":[116],"-18%":[117],"-11":[119],"mmHg,":[120],"respectively.":[121],"irbesartan-treated":[123],"patients,":[124],"85":[125],"(24.4%)":[126],"had":[127,144],"robust":[129,146],"(>median)":[130,147],"reduction":[131,148,161,190,242],"but":[134,151],"not":[135,152],"(discordant":[138,155],"response)":[140],"67":[142],"(19.3%)":[143],"response).":[157],"degree":[159],"was":[164,199,233],"independently":[165,234],"associated":[166,235],"eGFR":[171,237,245],"decline":[172,198],"(P":[173,181],"=":[174,182],"0.0037).":[175],"showed":[177],"similar":[179],"trend":[180],"0.087).":[183],"relation":[185],"between":[186],"larger":[188],"slower":[193],"function":[197],"present":[200],"cohorts":[203],"above":[208],"below":[210],"median.":[212],"CONCLUSIONS:":[213],"Within":[214],"an":[215],"individual,":[216],"ARB":[220],"therapy":[221,270],"may":[222],"be":[223,265],"discordant":[224],"from":[225],"response.":[227],"slope;":[238],"more":[240],"less":[244],"decline,":[246],"irrespective":[247],"change.":[251],"These":[252],"results":[253],"suggest":[254],"that":[255],"microalbuminuric":[257],"diabetes,":[262],"should":[264],"monitored":[266],"after":[267],"initiation":[268],"separate":[273],"target":[274],"for":[275],"renoprotective":[276],"therapy.":[277]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2096083860","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":11},{"year":2013,"cited_by_count":9},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
